Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-titer WNV-neutralizing Plasma for West Nile Fever
NCT07094724Phase 2Recruiting
- Start
- Jul 2025
- Primary completion
- Nov 2025
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of plasma rich with WNV neutralizing antibodies in West Nile fever. Started Jul 2025; status: recruiting.
02
Drugs
plasma rich with WNV neutralizing antibodies
03
Conditions
West Nile fever
Beyond the preview
Go deeper on NCT07094724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07094724.